Malignant tumors of the liver in children
Seminars in Pediatric Surgery, Volume 25, Issue 5, 2016, Pages 265-275
How I treat refractory immune thrombocytopenia
17:57
סגור לתגובות על How I treat refractory immune thrombocytopenia
BLOOD, 22 SEPTEMBER 2016 x VOLUME 128, NUMBER 12
BCR-ABL (Ph)-like acute leukemia – Pathogenesis, diagnosis and therapeutic options
14:29
סגור לתגובות על BCR-ABL (Ph)-like acute leukemia – Pathogenesis, diagnosis and therapeutic options
Ofran, Yishai et al.
Blood Reviews , Volume 31 , Issue 2 , 11 - 16
Cord-Blood Transplantation in Patients with Minimal Residual Disease
14:46
סגור לתגובות על Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano, Ted Gooley, Brent Wood, et al
N Engl J Med 2016; 375:944-953
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
16:54
סגור לתגובות על Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia
10:04
סגור לתגובות על Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia
The objective of this guideline is to provide healthcare professionals with guidance on the management of patients with
How I treat patients with a history of heparin-induced thrombocytopenia
12:16
סגור לתגובות על How I treat patients with a history of heparin-induced thrombocytopenia
Blood. 2016;128(3):348-359
How I treat patients with inherited bleeding disorders who need anticoagulant therapy
16:53
סגור לתגובות על How I treat patients with inherited bleeding disorders who need anticoagulant therapy
Situations that ordinarily necessitate consideration of anticoagulation, such as arterial and venous thrombotic events and prevention of stroke in atrial fibrillation, become
